EU ingredient rules · 1 min read

Acrylamide/ethalkonium Chloride Acrylate Copolymer in cosmetics: EU rules

Quick answer: Acrylamide/ethalkonium Chloride Acrylate Copolymer is a restricted cosmetic ingredient in the EU: Annex III (entry 66) allows it only within set limits. CosIng lists its functions as film forming, hair conditioning and viscosity controlling.

Key facts

Acrylamide/ethalkonium Chloride Acrylate Copolymer at a glance
INCI nameACRYLAMIDE/ETHALKONIUM CHLORIDE ACRYLATE COPOLYMER
CAS number74153-51-8
EU statusRestricted (Annex III, entry 66)
Functions (CosIng)Film forming, Hair conditioning, Viscosity controlling

CosIng description: 2-Propenamide, polymer with N-(2-benzyldimethylammonioethyl) 2-propenoate chloride

What it does in a product

  • Film forming: Leaves a thin, continuous layer on skin, hair or nails.
  • Hair conditioning: Makes hair easier to comb and leaves it softer or shinier.
  • Viscosity controlling: Thickens or thins a product.

Annex III: restricted substances, entry 66

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Polyacrylamides

Product type or body part:

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for ACRYLAMIDE/ETHALKONIUM CHLORIDE ACRYLATE COPOLYMER and Annex III/66, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.